MoneyWorks4Me

Shivalik Rasayan informs about filling of DMF

20 Aug 2021 Evaluate

Shivalik Rasayan has informed that the Company has successfully accomplished a major milestone by submitting its first US Drug Master File (DMF) in eCTD format for BORTEZOMIB through ESG gateway to USFDA today.

The above information is a part of company’s filings submitted to BSE.

Shivalik Rasayan Share Price

313.00 -12.30 (-3.78%)
03-Sep-2026 15:29 View Price Chart
Peers
Company Name CMP
UPL 580.05
PI Industries 2390.00
Bayer CropScience 3966.00
Sharda Cropchem 774.05
Sumitomo Chem. India 497.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: